Further update re Paraytec Limited

RNS Number : 1088B

Braveheart Investment Group plc

05 October 2020

 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

5 October 2020

Braveheart Investment Group plc

("Braveheart" or the "Group")

Further update re Paraytec Limited

Braveheart Investment Group (AIM: BRH), is pleased to provide an update concerning  progress with proof of concept for a COVID-19 test that Paraytec Limited is conducting with the University of Sheffield.

The Proof of Concept trials are focused on two separate elements of the test, the Optical Detection System, and Capture & Signal Generation Modules, both of which are required to be achieved for the trial to be successful. 

Proof of Concept has been achieved for the Optical Detection System and development work continues to optimise detection sensitivity. Minor logistical issues arising from increased regional COVID-19 restrictions has meant that final proof of concept trials continue for the Capture & Signal Generation Modules and the results are now anticipated on 16 October 2020.

For further information:

Braveheart Investment Group plc Tel: [phone] Viv Hallam, Executive Director Allenby Capital Limited (Nominated Adviser and Joint Broker) Tel: [phone] David Worlidge / James Hornigold Peterhouse Capital Limited (Joint Broker) Tel: [phone] Heena Karani / Lucy Williams

 

END

 

 

UPDFLFLIITLEIII